Differential gene expression during HIV-1 infection analyzed by suppression subtractive hybridization

AIDS

Volumn 18, Issue 4, 2004, Pages 587-596

  Yin, Jiyi ^a   Chen, Maria F ^b   Finkel, Terri H ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Apoptosis; cDNA; Gene expression; HIV 1 infection; Suppression subtractive hybridization

Indexed keywords

ACYL COENZYME A DEHYDROGENASE; ANNEXIN; COMPLEMENTARY DNA; DIHYDROFOLATE REDUCTASE; DNA BINDING PROTEIN; GAG PROTEIN; GENE PRODUCT; HEAT SHOCK PROTEIN 90; INITIATION FACTOR; ISOLEUCINE TRANSFER RNA; KARYOPHERIN BETA; LAMIN B; LIPOCORTIN 5; MATRILYSIN; MESSENGER RNA; MITOCHONDRIAL PROTEIN; PHOSPHOLIPASE A2; POLYADENYLATED RNA; PROTEIN TYROSINE PHOSPHATASE; PROTHYMOSIN ALPHA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; RNA BINDING PROTEIN; SMALL NUCLEAR RIBONUCLEOPROTEIN; SPERMIDINE SYNTHASE; TRANSCRIPTION FACTOR NFAT; TRANSFERRIN RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR; UBIQUINOL CYTOCHROME C REDUCTASE; UBIQUITIN CONJUGATING ENZYME; UNINDEXED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA LIBRARY; DNA SEQUENCE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOLECULAR CLONING; NICK END LABELING; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SUPPRESSION SUBTRACTIVE HYBRIDIZATION; T LYMPHOCYTE;

APOPTOSIS; BLOTTING, NORTHERN; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, VIRAL; GENE LIBRARY; GENES, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; NUCLEIC ACID HYBRIDIZATION;

EID: 1642302753     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200403050-00002     Document Type: Article

References (55)

1. Fauci AS. Host factors and the pathogenesis of HIV-induced disease. Nature 1996, 384:529-534.
2. McMichael A, Phillips RE. Escape of human immunodeficiency virus from immune control. Annu Rev Immunol 1997, 15: 271-296.
3. Finkel TH, Tudor-Williams G, Banda NK, Cotton MF, Curiel T, Monks C, et al. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV-and SIV-infected lymph nodes. Nat Med 1995, 1:129-134.
4. Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE, et al. Identification of a reservoir for HIV-and SIV-1 in patients on highly active antiretroviral therapy. Science 1997, 278:1295-1300.
5. Wong JK, Hezareh M, Gunthard HF, Havlir DV, Ignacio CC, Spina CA, et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 1997, 278:1291-1295.
6. Chun TW, Stuyver L, Mizell SB, Ehler LA, Mican JAM, Baseler M, et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci USA 1997, 94:13193-13197.
7. Perrin L, Telenti A. HIV treatment failure: Testing for HIV resistance in clinical practice. Science 1998, 280:1871-1873.
8. Nabel GJ. Challenges and opportunities for development of an AIDS vaccine. Nature 2001, 410:1002-1007.
9. LaCasse RA, Follis KE, Trahey M, Scarborough JD, Littman DR, Nunberg JH. Fusion-competent vaccines: broad neutralization of primary isolates of HIV. Science 1999, 283:357-362.
10. Landau NR. Recent advances in AIDS research: genetics, molecular biology and immunology. Curr Opin Immunol 1999, 11: 449-450.
11. Rowland-Jones S, Pinheiro S, Kaul R. New insights into host factors in HIV-1 pathogenesis. Cell 2001, 104:473-476.
12. Press release: amfAR awards over $1 million in grants to identify viral and cellular targets for new AIDS drugs. Website: http:// www.amfar.org/pages/pr43.html.
13. Progress against HIV: the need for new treatments for AIDS is more urgent than ever. Nat Biotech 2000, 18(suppl):IT27-IT29.
14. Pantaleo G, Fauci AS. Immunopathogenesis of HIV infection. Annu Rev Microbiol 1996, 50:825-854.
15. Ross TM. Using death to one's advantage: HIV modulation of apoptosis. Leukemia 2001, 15:332-341.
16. Emerman M, Malim M. HIV regulatory/accessory genes: keys to unraveling viral and host cell biology. Science 1998, 280: 1880-1884.
17. 7. Casella CR, Rapaport EL, Finkel TH. Vpu increases susceptibility of human immunodeficiency virus type-1-infected cells to Fas killing. J Virol 1999, 73:92-100.
18. Geleziunas R, Xu W, Takeda K, Ichijo H, Greene WC. HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell. Nature 2001, 410:834-838.
19. Wolf D, Witte V, Laffert B, Blume K, Stromer E, Trapp S, et al. HIV-1 Nef associated PAK and PI3-kinases stimulate Akt-independent Bad-phosphorylation to induce anti-apoptotic signals. Nat Med 2001, 7:1217-1224.
20. Ameisen JC. Apoptosis subversion: HIV-Nef provides both armor and sword. Nat Med 2001, 7:1181-1182.
21. Bushman F, Landau NR, Emini EA. New developments in the biology and treatment of HIV. Proc Natl Acad Sci USA 1998, 95:11041-11042.
22. Shahabuddin M, McKinley G, Potash MJ, Volsky DJ. Modulation of cellular gene expression of HIV type 1 infection as determined by subtractive cloning: downregulation of thymosin beta 4 in vitro and in vivo. AIDS Res Hum Retroviruses 1994, 10:1525-1529.
23. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, et al. Identification of a major co-receptor for primary isolates of HIV. Nature 1996, 381:661-666.
24. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply exposed individuals to HIV infection. Cell 1996, 86:367-377.
25. Murdoch C. CXCR4, chemokine receptor extraordinaire. Immunol Rev 2000, 177:175-184.
26. Posada R, Pettoello-Mantovani M, Sieweke M, Graf T, Goldstein H. Suppression of HIV type 1 replication by a dominant-negative Est-1 mutant. AIDS Res Hum Retroviruses 2000, 16:1981-1989.
27. Nekhai S, Shukla RR, Fernandez A, Kumar A, Lamb NJ. Cell cycle-dependent stimulation of the HIV-promoter by Tatassociated CAK activator. Virology 2000, 266:246-256.
28. Cron RQ, Bartz SR, Clause A, Bort SJ, Klebanoff SJ, Lewis DB. NFAT1 enhances HIV-1 gene expression in primary human CD4 cells. Clin Immunol 2000, 94:179-191.
29. Kinoshita S, Chen BK, Kaneshima H, Nolan GP. Host control of HIV-1 parasitism in T cells by the nuclear factor of activated T cells. Cell 1998, 95:595-604.
30. Kinoshita S, Su L, Amano M, Kaneshima H, Nolan GP. The T cell activation factor NF-ATc positively regulates HIV-1 replication and gene expression in T cells. Immunity 1997, 6:235-244.
31. Scheuring UJ, Sabzevari H, Corbeil J, Theofilopoulos AN. Differential expression profiles of apoptosis-affecting genes in HIV-infected cell lines and patient T cells. AIDS 1999, 13:167-175.
32. Selliah N, Finkel TH. JAK3 activation and rescue of T cells from HIV gp120-induced unresponsiveness. J Immunol 1998, 160:5697-5701.
33. Selliah N, Finkel TH. Biochemical mechanisms of HIV induced T cell apoptosis. Cell Death Diff 2001, 8:127-136.
34. Sheehy AM, Gaddis NC, Choi JD, Malim MH. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 2002, 418:646-650.
35. Finkel TH, Casella CR. AIDS and cell death. In: When Cells Die. Edited by Lockshin RA, Zakeri Z, Tilly JL. New York: Wiley-Liss; 1998:289-318.
36. Folks TM, Powell D, Lightfoote M, Koenig S, Fauci AS, Benn S, et al. Biological and biochemical characterization of a cloned Leu-3-cell surviving infection with the acquired immune deficiency syndrome retrovirus. J Exp Med 1986, 164:280-290.
37. Hoxie JA, Haggarty BS, Rackowski JL, Pillsbury N, Levy JA. Persistent noncytopathic infection of normal human T lymphocytes with AIDS-associated retrovirus. Science 1985, 229: 1400-1402.
38. Popovic M, Sarngadharan MG, Read E, Gallo RC. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 1984, 224:497-500.
39. Levy JA, Hopffman AD, Kramer SM, Landis JA, Shimabukuro JM, Oshiro LS. Isolation of lymphocytic retrovirues from San Francisco patients with AIDS. Science 1984, 225:840-842.
40. Simm M, Su Z, Huang EY, Chen Y, Jiang H, Volsky DJ, et al. Cloning of differentially expressed genes in an HIV-1 resistant T cell clone by rapid subtraction hybridization, RaSH. Gene 2001, 269:93-101.
41. Ryo A, Suzuki Y, Ichiyama K, Wakatsuki T, Kondoh N, Hada A, et al. Serial analysis of gene expression in HIV-1-infected T cell lines. FEBS Lett 1999, 462:182-186.
42. Geiss GK, Bumgarner RE, An MC, Agy MB, van't Wout AB, Hammersmark E, et al. Large-scale monitoring of host cell gene expression during HIV-1 infection using cDNA microarrays. Virology 2000, 266:8-16.
43. Corbeil J, Sheeter D, Genini D, Rought S, Leoni L, Du P, et al. Temporal gene regulation during HIV-1 Infection of human CD4+ T cells. Genome Res 2001, 11:1198-1204.
44. Diatchenko L, Lau YF, Campbell AP, Chenchik A, Moqadam F, Huang B, et al. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci USA 1996, 93: 6025-6030.
45. Oukka M, Ho IC, de la Brousse FC, Hoey T, Grusby MJ, Glimcher LH. The transcriptional factor NFAT4 is involved in the generation and survival of T cells. Immunity 1998, 9:295-304.
46. Duan H, Wang Y, Aviram M, Swaroop M, Loo JA, Bian J, et al. SAG, a novel zinc ring finger protein that protects cells from apoptosis induced by redox agents. Mol Cell Biol 1999, 19:3145-3155.
47. Swaroop M, Gosink M, Sun Y. SAG/ROC2/Rbx2/Hrt2, a component of SCF E3 ubiquitin ligase: genomic structure, a splicing variant, and two family pseudogenes. DNA Cell Biol 2001, 20:425-434.
48. Sun Y, Tan M, Duan H, Swaroop M. SAG/ROC2/Rbx2/Hrt2, a zinc RING finger gene family: molecular cloning, biochemical properties, and biological functions. Antioxid Redox Signal 2001, 3:635-650.
49. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 1991, 10:2247-2258.
50. Galea-Lauri J, Richarson AJ, Latchman DS, Katz DR. Increased heat shock protein 90 expression leads to increased apoptosis in the monoblastoid cell line U937 following induction with TNFα and cycloheximide. J Immunol 1996, 157:4109-4118.
51. Pandey P, Saleh A, Nakazawa A, Kumar S, Srinivasula SM, Kumar V, et al. Negative regulation of cytochrome c-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protien 90. EMBO J 2000, 19:4310-4322.
52. Lewis J, Miller A, Lin Y, Rodriguez Y, Neckers I, Liu ZG. Disruption of Hsp90 function results in degradation of the death domain kinase, receptor-interacting protein(RIP) and blockage of tumor necrosis factor-induced nuclear factor -kappaB activation. J Biol Chem 2000, 275:10519-10526.
53. Wu Y, Kita K, Suzuki N. Involvement of human heat shock protein 90α in nicotine-induced apoptosis. Int J Cancer 2002, 100:37-42.
54. Brenner BG, Wainberg Z. Heat shock protein: novel therapeutic tools for HIV-infection. Expert Opin Biol Ther 2001, 1:67-77.
55. Shoshani T, Faerman A, Mett I, Zelin E, Tenne T, Gorodin S, et al. Identification of a novel hypoxia-inducible factor 1-responsive gene RTP801, involved in apoptosis. Mol Cell Biol 2002, 22:2283-22931.